HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity is well positioned because it is deepening a differentiated, technology-enabled platform that expands member engagement and monetization, as evidenced by 1.4M+ monthly active users in July, 5M+ total downloads, 14,000+ active marketplace members, and a record 500,000 unique visitors last week, while AI and automation are already supporting higher margins and a better user experience. Its core HSA franchise is still taking share, with total HSA members up 8% y/y, custodial assets up 14% y/y, total accounts up 4% y/y, new HSA sales up 24% y/y, and renewals on pace to be well above 90%+, all of which point to durable demand and strong retention in a market benefiting from rising HDHP adoption and improving eligibility rules. Financial execution reinforces the positive outlook, as the company delivered $350.7M of revenue (+7.6% y/y), $167M of adjusted EBITDA (+11% y/y), and a company-high EBITDA margin of ~48%, while management’s ability to reprice about $2.3B of HSA cash in 2027 at higher rates should further support custodial revenue and operating leverage.

HealthEquity is facing a negative outlook because its core growth engine is highly sensitive to labor-market weakness and balance accumulation, and the source text explicitly warns that unemployment above 5% can materially slow HSA balance growth while also flagging a cautious view on 2026 labor conditions. Even though the company benefits from an expanding TAM, AI-driven service-cost leverage, and potential regulatory tailwinds such as the OBBBA’s expansion to approximately 8mm new HSA-eligible ACA Bronze lives, those positives are offset by risks from falling interest rates and investment returns, rising competition, alternative payment methods, cyber-security attacks, and unfavorable regulatory changes. From a financial perspective, the text implies the market may already be discounting slower growth and margin contraction, citing a $79 downside scenario based on 13x FY2027 EBITDA, 5% topline growth, and 200bps of margin contraction in 2027, which suggests limited upside if execution or macro conditions disappoint.